1. Home
  2. MBIN vs NKTR Comparison

MBIN vs NKTR Comparison

Compare MBIN & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merchants Bancorp

MBIN

Merchants Bancorp

HOLD

Current Price

$54.87

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$69.96

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBIN
NKTR
Founded
1990
1990
Country
United States
United States
Employees
735
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.2B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
MBIN
NKTR
Price
$54.87
$69.96
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$43.67
$146.67
AVG Volume (30 Days)
143.9K
780.6K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
0.89%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$307,711,000.00
Revenue This Year
$31.76
N/A
Revenue Next Year
$3.73
N/A
P/E Ratio
$12.29
N/A
Revenue Growth
N/A
86.00
52 Week Low
$29.20
$21.60
52 Week High
$56.87
$109.00

Technical Indicators

Market Signals
Indicator
MBIN
NKTR
Relative Strength Index (RSI) 73.49 53.68
Support Level $45.39 $64.28
Resistance Level N/A $76.78
Average True Range (ATR) 1.76 3.30
MACD 0.79 0.12
Stochastic Oscillator 89.97 62.78

Price Performance

Historical Comparison
MBIN
NKTR

About MBIN Merchants Bancorp

Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: